Swiss Chemicals Stock News

In recent weeks, SaltX Technology announced a Joint Development Agreement with Holcim to co-develop and pilot a fully electrified, fossil-free clinker production process in Europe, targeting the world’s first fully electric cement plant by 2028 and advancing electrified calcination and sintering technologies that can be retrofitted or built into new facilities. By pairing this deep-process electrification push with Holcim’s broader moves in low‑carbon manufacturing and equipment procurement,...

Galderma Group stock: recent performance snapshot Galderma Group (SWX:GALD) has drawn fresh attention after a period of mixed share performance, including a 0.3% move over the past day and a negative return over the past month and past 3 months. See our latest analysis for Galderma Group. That recent 7 day and 90 day share price weakness, with a 7 day share price return of a 1.93% decline and a 90 day share price return of a 13.16% decline from CHF142.5, contrasts with a 1 year total...

Emmi dropped from FTSE All-World Index puts index-tracking flows in focus Emmi (SWX:EMMN) has been removed from the FTSE All-World Index (USD), an index change that can influence trading activity for funds tracking the benchmark and draw attention to the company’s CHF 4.36b market value. See our latest analysis for Emmi. Emmi’s latest index exit comes after a 90 day share price return of 11.8% and a year to date share price return of 14.0%, while the 1 year total shareholder return of 3.4%...

Index removal puts Adecco in focus for income minded investors Adecco Group (SWX:ADEN) has been removed from the FTSE All-World Index (USD), a shift that can prompt portfolio adjustments by index trackers, while its confirmed CHF 1.00 per share annual dividend keeps income considerations in view. See our latest analysis for Adecco Group. At a share price of CHF18.21, Adecco’s 30 day share price return of 15.46% and year to date share price return of 22.38%, alongside a 1 year total...

DKSH Holding (SWX:DKSH) has been removed from the FTSE All-World Index (USD), an index change that can influence trading flows as index-tracking investors and funds rebalance their portfolios. See our latest analysis for DKSH Holding. At a share price of CHF57.4, DKSH Holding has seen a 9.32% 1 month share price decline and a 19.05% 1 year total shareholder return decline, suggesting momentum has been fading even before the index removal headline. If this kind of index reshuffle has you...

Idorsia (SWX:IDIA) is back in focus after announcing that CEO Dr. Srishti Gupta will step down and also leave the Board of Directors. Chairman Jean Paul Clozel will take over as interim CEO. See our latest analysis for Idorsia. The leadership change comes after a mixed period for investors, with the latest CHF3.15 share price sitting against a 1 day share price return of 2.27%, a 30 day share price return of a 14.75% decline, and a very large 1 year total shareholder return of about 3x...

Compagnie Financière Tradition (SWX:CFT) has reported FY 2025 results with first half revenue of CHF 575.4 million and basic EPS of CHF 9.14, while trailing twelve month revenue came in at about CHF 1.1 billion with EPS of CHF 16.25 and earnings growth of 21.7% over the past year. Over recent periods the company has seen revenue move from CHF 533.4 million and EPS of CHF 7.98 in 1H 2024 to CHF 510.5 million and EPS of CHF 7.13 in 2H 2024, before reaching the latest 1H 2025 levels. This sets...

Liechtensteinische Landesbank (SWX:LLBN) has drawn investor attention after issuing a CHF 200 million senior preferred bond, a ten year fixed rate instrument that met strong demand and references the bank’s solid capital position. See our latest analysis for Liechtensteinische Landesbank. The bond issue comes as the share price trades at CHF98.8, with a 1-day share price return of 1.96% and a 90-day share price return of 18.61%. The 1-year total shareholder return of 28.92% and 5-year total...

Novartis (SWX:NOVN) agreed to acquire a selective breast cancer therapy targeting PI3Kα mutations from Synnovation Therapeutics for up to US$3b. The oral therapy is aimed at HR+/HER2- breast cancer with PI3Kα mutations, addressing a major unmet treatment need. The deal is intended to strengthen Novartis's targeted oncology portfolio in a competitive cancer drug market. For investors watching big pharma, this move puts a fresh spotlight on Novartis's focus on targeted cancer medicines...

Assessing Alcon after recent share price pressure Alcon (SWX:ALC) has come under pressure recently, with the share price showing negative returns over the past month and past 3 months. This puts the focus on what current fundamentals might imply for investors. See our latest analysis for Alcon. Beyond the recent pullback, Alcon’s share price return has been weak over the year, and the 1 year total shareholder return of a 26.9% decline underlines that pressure has been sustained rather than a...

Galderma Group (SWX:GALD) has scheduled a virtual Annual General Meeting that will focus on corporate governance changes. The AGM agenda includes new board nominations linked to major shareholder L’Oréal and a proposed dividend. Management plans to discuss L’Oréal’s influence as an investor following a period of record company performance. Galderma Group operates in the dermatology and skincare segment, an area that continues to attract consumer interest as spending on skin health and...

Roche Holding (SWX:ROG) has drawn investor attention after recent price moves, with the share price around CHF 322.30 and mixed short term returns contrasting with stronger multi year total return figures. See our latest analysis for Roche Holding. Recent trading has been choppy, with a 1 month share price return showing a decline of 10.47% and a year to date share price return showing a decline of 0.98%, contrasting with a 1 year total shareholder return of 10.30%. This suggests that recent...

If you are wondering whether UBS Group's current share price offers value or just noise, the recent performance gives you plenty to think about. The stock trades at CHF 29.08, with a 0.7% decline over the last week, a 12.9% decline over the last month, a 23.8% decline year to date, a 4.2% gain over 1 year, 83.3% over 3 years and 120.0% over 5 years. These moves sit against a backdrop of ongoing integration work following the Credit Suisse acquisition and continuing market attention on UBS...

Swiss Re (SWX:SREN) has attracted fresh attention after striking a US$2b longevity reinsurance deal with Athene, its first covering US retirees and a step that broadens its role in global pension risk transfer. See our latest analysis for Swiss Re. The longevity deal and recent leadership change in the Asia Pacific life and health unit come as Swiss Re’s share price sits at CHF128.0, with a small year to date share price decline and a much stronger multi year total shareholder return profile...

Recent share performance and business overview SMG Swiss Marketplace Group Holding (SWX:SMG) has drawn interest after a period of weaker share performance, with the stock closing at CHF 26.35 and showing negative returns over the past week, month and past 3 months. The company runs online marketplaces across real estate, automotive and general classifieds in Switzerland. It earned CHF 358.843m in revenue and CHF 67.694m in net income, supported by reported annual revenue and net income growth...

Nestlé Holdings has completed a major cash tender offer for its outstanding notes, purchasing all securities that were validly tendered. The transaction used available liquidity and may have involved intra group distributions from Nestlé, affecting how debt is positioned within the group. This liability management move changes the mix of outstanding debt and could affect interest costs and balance sheet flexibility over time. For readers tracking SWX:NESN, this development comes with the...

Partners Group Holding (SWX:PGHN) is back in the spotlight after a Bank of America note highlighted its exposure to potential private credit shocks, just as the chair mentioned a possible doubling of default rates. See our latest analysis for Partners Group Holding. The recent Bank of America note appears to have reinforced concerns around private credit risk. This lines up with Partners Group Holding's 1 month share price return of 14.86% decline and year to date share price return of 22.02%...

Swiss Life Holding (SWX:SLHN) just combined its 2025 earnings release with an increased annual dividend of CHF 36.50 per share, a pairing that tends to draw income focused investors’ attention. See our latest analysis for Swiss Life Holding. The share price has softened recently, with a 1 month share price return of 3.15% and a 90 day share price return of 8.72%. However, the 1 year total shareholder return of 10.22% and 5 year total shareholder return of 127.70% point to stronger longer term...

Givaudan, ticker SWX:GIVN, is participating in the Future Food-Tech San Francisco event. The company is highlighting its front end innovation capabilities, with its Head of Front End Innovation presenting. The event participation puts a spotlight on Givaudan's role in emerging food technology trends and potential collaboration opportunities. Givaudan enters this conference with its share price at CHF2,701.0 and a value score of 4, reflecting how some investors may currently view the stock...

Dividend announcement and earnings call set the tone Stadler Rail (SWX:SRAIL) has attracted fresh attention after announcing an annual dividend of CHF 0.50 per share, alongside its 2025 earnings call held on 18 March 2026. The dividend is scheduled for payment on 11 May 2026, with the shares trading ex dividend on 7 May and a record date of 8 May. This provides investors with clear timelines around the cash distribution. See our latest analysis for Stadler Rail. Stadler Rail’s CHF 19.67 share...

Swissquote Group Holding (SWX:SQN) has put up a busy FY 2025 scorecard, with second half revenue of CHF 388.1 million and basic EPS of CHF 13.88 sitting alongside trailing twelve month revenue of CHF 760.8 million and EPS of CHF 24.49, underpinned by reported earnings growth of 24.6% over the last year. The company has seen revenue move from CHF 356.9 million in the second half of 2024 to CHF 372.7 million in the first half of 2025 and CHF 388.1 million in the second half of 2025, while net...

DocMorris (SWX:DOCM) has released fresh numbers for FY 2025, with first half revenue of CHF 541.5 million and a basic EPS loss of CHF 2.11 setting the tone, while over the trailing twelve months revenue reached CHF 1.1 billion against a basic EPS loss of CHF 3.47. Over recent periods, revenue has moved from CHF 496.3 million in H1 2024 to CHF 520.8 million in H2 2024 and CHF 541.5 million in H1 2025, as EPS has remained negative across all these halves. For investors, this mix of higher sales...

Swatch Group (SWX:UHR) has delivered a soft set of FY 2025 numbers, with second half revenue of CHF 3.2b and net income excluding extra items of essentially break even, alongside a current share price of CHF 164.45. The company has seen half year revenue move from CHF 3.3b in second half 2024 to CHF 3.1b in first half 2025 and CHF 3.2b in second half 2025. Net income excluding extra items shifted from CHF 57m to CHF 3m and then to zero over the same periods, setting up a story where wafer...

Logitech International (SWX:LOGN) has appointed Yalcin Yilmaz as its new Chief Commercial Officer, marking a key shift in its leadership team. The board has approved a new three year share buyback program, signaling a clear capital return plan for shareholders. The company has expanded its Racing Series Ecosystem with the launch of the RS H Shifter, adding a fresh product to its simulation portfolio. Logitech International, trading at CHF71.12, sits at an interesting point for investors...